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Summary The properties of a new tumour cell line (NB 1-G) derived from human neuroblastoma by
xenografting in nude rats followed by adaptation to tissue culture are described. Studies using a panel of
monoclonal antibodies demonstrate the neuro-ectodermal nature of the cells and support the diagnosis of the
primary tumour as neuroblastoma. Cytogenetic studies have revealed a human karyotype with several
chromosomal abnormalities. Genetic analysis by in situ DNA hybridization has demonstrated the presence
of multiple copies of the N-myc gene. Approximately 20-30 fold amplification of the gene is observed on
Southern blot analysis. The cell line has been adapted to growth as multicellular tumour spheroids as well as
monolayer culture. Radiobiological studies on spheroids show the cells to be radiosensitive with low capacity
for sub-lethal damage accumulation and repair. The cell line should be useful for fundamental studies of
human neuroblastoma as well as experimental therapy in vitro.
Neuroblastoma is a malignant tumour of neural crest origin.
It is the most common extracranial malignant solid tumour
in childhood and accounts for 10% of childhood
malignancies (Jaffe, 1976; Breslow & McCance, 1971).
Abdominal neuroblastoma accounts for 70% of all sites and
presents clinically at a late stage (Carachi et al., 1983).
Survival for this group is only 15-20% even after the most
aggressive therapy. New approaches to treatment are
evidently required and might be investigated using
appropriate laboratory models. In this paper we describe the
biological and radiobiological properties of a new cell line
(NB1-G) derived via xenografting from human neuro-
blastoma. This cell line may be grown in conventional
monolayer culture or as multicellular tumour spheroids.
Materials and methods
Origin ofthe tumour
The patient presented in 1979 aged 18 months with an
abdominal mass and a right pleural effusion. At laparotomy,
a large retroperitoneal haemorrhagic tumour was found
arising from the right suprarenal region. The tumour crossed
the midline and infiltrated the diaphragm. The liver was free
of disease. A biopsy was taken which confirmed the presence
of a neuroblastoma which was considered to be Stage IV.
The pleural effusion was tapped and found to be full of
neuroblastoma cells. Both solid tumour from the biopsy and
cells from the pleural effusion were taken for xenografting.
The patient died in the early post-operative period before
any therapy could be instituted.
Xenograft procedure
Tumour fragments from the biopsy were aseptically
implanted in nude rats using a wide bore needle. The
procedure entailed the needle entering at the right flank then
being tunnelled to the right axilla where the tumour
fragment was deposited. This reduces tumour loss, and also
facilitates vascularization from the axillary vessels. This led
to the development of a viable transplantable tumour as
described below. (Cells from the pleural effusion were
implanted i.p. but did not result in tumour growth.)
The latent period before detectable tumour growth was 11
weeks. Thereafter the tumour grew from 0.5 cm diameter to
3 cm in a period of 3 weeks. The tumour was passaged 17
times in nude rats before storage in liquid nitrogen. During
this time, the morphology of the tumour by light microscopy
and EM remained similar to that of the original tumour in
the patient. In 1984 the tumour line was successfully recalled
and passaged once in nude rats. The tumour was surgically
excised, minced and disaggregated by digestion with trypsin
followed by vigorous pipetting. The resultant tumour cell
suspension was then taken for in vitro studies.
Monolayer culture
Disaggregated tumour cells were established in monolayer
culture and routinely subcultured thereafter. Approximately
3 x 105 cells were plated in a 75cm2 tissue culture flask
(Sterlin) in 20ml Eagle's Minimum Essential Medium
(MEM) with 15% foetal calf serum in presence of antibiotics
(penicillin, streptomycin, fungizone). Flasks were maintained
at 37C in an atmosphere of 7% CO2 at 100% humidity.
The cells were sub-cultured weekly.
Testing for mycoplasma was carried out in antibiotic-free
conditions. The cells were found to be mycoplasma-free.
Tumour spheroid culture
Spheroid cultures were initiated using a modification of the
method of Yuhas et al. (1977). Approximately 106 cells were
obtained by trypsinization of monolayer cultures and were
placed in 25cm2 tissue culture flask (Sterlin) previously base-
coated with 1% Noble agar, containing 5ml MEM with
15% foetal calf serum and antibiotics as above. The flasks
were then incubated as for monolayer cultures. Small
spheroids usually formed within a few days. For radiobio-
logical studies, individual spheroids were transferred by
Pasteur pipette to agar-coated wells in 24-well test plates
(Linbro), each well containing 0.5ml complete medium, for
further incubation with periodic observation of growth as
described below. The medium in the wells was 'topped up'
weekly by addition of a further 0.5ml complete medium.
Experiments have shown that this 'top-up' procedure results
in nearly identical spheroid growth patterns to those
resulting from regular medium replacement.
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Cytogenetic studies
These studies were carried out using NB1-G cells in mono-
layer. Twenty-four hours after subculturing, cells were
treated with colcemid as an arresting agent for h then
shaken off, centrifuged and treated with hypotonic solution
(serum-free RPMI 1640 diluted with distilled water 1:4) for
6min at room temperature. Cells were centrifuged and fixed
in three changes of 1:3 acetic acid:methanol. Spreads aged
4-6 days were banded by the SSC-trypsin-Giemsa method
(Gallimore & Richardson, 1973).
Monoclonal antibodies
The cells were tested for antigen specificity using a panel of
monoclonal antibodies including those used in the
differential diagnosis of neuroblastoma from Ewing's
sarcoma and rhabdomyosarcoma (Sugimoto et al., 1985).
The full panel is specified in Table I. Cells were harvested
using trypsin and washed twice in PBS. Cells (5 x 105 -
1 x 106) were incubated with each for 30min at 4°C in
antibody excess. After washing, binding of antibody was
detected using fluorescein-conjugated F(ab)'2 goat antimouse
immunoglobulin (Ig), previously affinity-purified and
absorbed with human Ig and pig liver powder. Samples were
examined with a Zeiss photomicroscope III with epi-
illumination optics.
In situ DNA hybridization
A study was carried out to test for the presence of the N-
myc gene. 1 Mg of the N-myc probe p Nb-I was labelled with
3H by nick translation to specific activity of 10-7dpm using
all four 3H labelled deoxynucleotide triphosphates
(Amersham International plc) and hybridized in situ to
chromosomes of NB1-G prepared as described above using
the methods described previously (Mitchell et al., 1985). The
slides were dipped in Ilford L4 nuclear emulsion and exposed
at 4°C for 10 days before developing and staining as
previously described (Joseph et al., 1984).
Southern blot analysis
Genomic DNA was prepared by a standard method
(Maniatis et al., 1982). Samples were digested with Eco RI,
electrophoresed through 0.8% agarose and blotted onto
nitrocellulose (Southern, 1975). Filters were hybridized with
nick-translated 32P-labelled p Nb-I DNA (0.1 pg of specific
activity 2 x 108 cpmpg-1) (Rigby et al., 1977). Hybrid-
izations were done overnight at 68°C in a buffer of 5 x SSC,
0.1% SDS, 0.1% sodium pyrophosphate, 5 x Denhardt's
solution, 10% dextran sulphate, 100pgml-1 sonicated
salmon sperm DNA. Washings were done in 0.1 x SSC,
0.1% sodium pyrophosphate at 68°C. Autoradiograph
exposures were for 48h using intensifying screens and Kodak
XAR5 film.
Radiobiological studies on tumour spheroids
Irradiation studies were carried out to assess the radio-
sensitivity of NBl-G cells in spheroid culture. All irradiation
experiments made use of a 4 Mev linear accelerator. The
radiation dose rate was -2Gymin-i. Prior to irradiation,
individual spheroids of diameter -200-250 pM were selected
by Pasteur pipette and transferred to 24 well test plates
(Linbro). Spheroids were irradiated in wells and the plates
returned to the incubator. Doses in the range 50-350cGy
were administered. Assessment of spheroid growth was
carried out by three-times weekly measurement of cross-
sectional area of each spheroid using a 'Micromeasurements'
'40-10' image analysis scanner (see Twentyman, 1982). The
measured areas were converted to volumes, assuming
spherical geometry and growth curves constructed by taking
median spheroid volume for each experimental group on
each day of measurement. The size range covered the growth
curve observations (250rM-1,000pM diameter) corres-
ponding - very roughly - to an increase in cell number of
from '-5 x 102 to -3 x 104 cells.
Results
Monoclonal antibody studies
The results of testing NBI-G cells against the panel of
monoclonal antibodies are summarized in Table I. As may
be seen, the cells display a predominantly neuro-ectodermal
pattern of specificities. By these criteria, previously used in
the differential diagnosis of neuroblastoma from Ewing's
sarcoma and rhabdomysarcoma (Sugimoto et al., 1985),
NB1-G cells are considered to have antigenic specificities
typical of a neuroblastoma.
Chromosome analysis
The quality of chromosome preparations obtained was not
good and relatively few cells could be analysed fully. The
modal number of chromosomes was 49. The distribution of
chromosome number in 27 cells scored was 45(1), 46(2),
47(5), 48(5), 49(12), 50(2). A number of abnormal
chromosomes were observed. In every cell stored there were
three copies of chromosomal, all abnormal: one with an
extra dark and light band at the top of Ip and two with
large HSRs on the distal end of lp. These HSRs were not
strictly 'homogeneously staining regions', having some
closely apposed dark and light bands in some cells. This is in
agreement with other reports of HSRs. An abnormal
chromosome 16 was observed in almost every cell examined.
Trisomy 6 occurred in at least 75% of cells and trisomy 7 in
50%. A typical karyotype is shown in Figure 1. There were
some other apparently random abnormalities.
In situ DNA hybridization
Figure 2 shows the autoradiograph of a typical cell after
hybridization in situ with pNb-1. Both chromosomes 1
carrying HSRs show heavy labelling within the HSR.
However the label is not distributed uniformly over the
whole region in either chromosome but is restricted to a
Table I Monoclonal antibody panel used in antigenic character-
ization of NBI-G cells
Antibody Reactivity Specificity
BA-1 + B-Cell associated
UJ13A + + + Almost pan-neuroectodermal
UJ127.11 + Neural (rather than glial)
UJ308 + + + Neural, neuroblastoma, myeloid
(25% ofcells) (promyelocytes and granulocytes)
UJ181.4 -/+ Foetal brain, primitive neural
tumours
UJ223.8 + + + Neuroblastoma and primitive
tumours
UJ167.11 +/+ + Neuroblastoma and primitive
tumours
P1153/3 + + + Neural, pre-B ALL, common ALL
(25% ofcells)
ac-Thy-i + Thy-I antigen
H 1I + + As UJ13A (but not same antigen)
MINI - As UJ308
A2B5 + + + Neural
(25% ofcells)
2D-1 - Lymphoid (T and B cells)
W6/32 - HLA class I, monomorphic
FD44 - Endothelial
FD32.2 - Extracellular matrix of several
tumours
a-Desmin - Striated muscle and associated
tumours
a-Vimentin + + + Pan-mesenchyme and tumoursFigure 1 Typical karyotype for NBl-G cells.
Figure 2 Autoradiograph of typical NBl-G cell after hybridization in situ with p Nb-l. Solid arrows mark the heavy label on the
HSR regions of the two abnormal chromosomes 1. The open arrow indicates the unlabelled normal chromosome 1.
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relatively small area and it appears that the HSRs contain
other sequences as well as the amplified N-myc genes. This
may be similar to the HSR in the neuroblastoma cell line
IMR-32 which contains amplified sequences derived from
other regions of the chromosome 2 short arm (Shiloh et al.,
1985).
Southern blot analysis
A panel of serial dilutions of Eco RI digested DNA from the
neuroblastoma cell line NB1-G were probed with the N-myr-
specific probe pNb-l (Schwab et al., 1983t. The inten-sity of
the resulting signals were compared with those of Eco RI
digested placental DNA samples which were used as controls
(Figure 3). All samples tested showed the presence of a
hybridising Eco RI restriction fragment of -2.1 kbp as
predicted from the restriction map of the human N-myc
locus (Schwab et al., 1983). The intensity of the signals seen
in the placental DNA samples were the same as those
obtained in hybridizations done on numerous fresh tissue
and blood DNA samples (data not shown) and therefore
represents the normal copy number of the N-myc gene. The
estimated amplification factor of the N-myc gene locus in the
cell line NBI-G is -20-30 (Figure 3).
Radiobiological studies
Growth curves for control and irradiated spheroids are
shown in Figure 4a. There is a progressive displacement of
growth curves to the right as the radiation dose increases.
Attempts were made to deduce 'in situ cell survival curves'
from these spheroid growth data by extrapolation of the
regrowth curves to zero time. The rationale for this
procedure has been considered elsewhere (Wheldon et al.,
1985). A calculated curve was obtained relating the radiation
dose to the estimated surviving fraction of cells in the
spheroids of each experimental group, and is depicted in
Figure 4b. A computer fit was made of the multitarget
function
S=( -(1-Exp(-D/Do))")
(where D is given dose) to these calculated survival data and
this yielded estimates of the radiobiological parameters n and
Do for NB-1G cells grown as spheroids. The parameter Do is
the reciprocal slope of the survival curve in the experimental
(high dose) region. It is inversely related to cellular radio-
sensitivity at high doses. The parameter n, the extrapolation
number, is obtained by the linear extrapolation of the
a
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Figure 3 Southern blot analysis of DNA from NBI-G cells, to
estimate the amplification of the N-myc gene locus. Lanes A-F.
Serial dilutions of Eco RI digested DNA from NBI-G. Lane A -
5jig DNA; Lane B - 2.5pg DNA; Lane C - 1.25pg DNA; Lane
D - 0.625pg DNA; Lane E - 0.313.ug DNA; Lane F - 0.156pg
DNA; Lane G- 10 g digested placental DNA; Lane H - 5jg
digested placental DNA.
exponential portion of the curve to meet the Y-axis. It is a
measure of the ability of the cell line to repair low-dose
radiation damage. Best estimates were found to be n- 1.2
and Do 0-1.04cGy. These values are indicative of a
moderately radiosensitive cell line with little capacity for
repair of low-dose damage.
Discussion
Though a number of human neuroblastoma cell lines have
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Figure 4 Summary of results obtained on radiation sensitivity of NB1-G spheroids. (a) Regrowth curves of NBI-G spheroids
after various doses of radiation. * * Control; ---O cGy; A---A 1OOcGy; X X 150cGy; A A 250cGy;
+-- + 350cGy. (b) Cell survival curve for NB1-G cells in spheroids calculated from regrowth data.
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extensive biological characterization as reported here. Such
characterization is necessary if the line concerned is to be
used to derive inferences as to the biology of neuroblastoma,
or to employ in vitro cells in experimental studies of new
approaches to neuroblastoma treatment.
The cytogenic studies not only confirm the human origin
of the cell line but demonstrate additional features associated
with neuroblastoma. NBI-G has an abnormal human
karyotype with two copies of chromosome 1 possessing very
similar homogeneously staining regions. A third chromosome
1 does not possess such an HSR. The oncogene N-myc
whose normal cellular counterpart has been assigned to the
short arm of chromosome 2 is observed by in situ hybrid-
ization to be in the HSR on the abnormal chromosomes 1
(see Shiloh et al., 1985). Quantitative analysis by Southern
hybridization shows about 24 fold amplification of the N-
myc oncogene in NBI-G. The existence of HSRs and of the
amplified N-myc gene are similar to that reported for other
neuroblastoma cell lines and are features which may be
associated with tumour progression (Brodeur et al., 1985).
The radiobiological studies demonstrate that NBI-G cells
grown as spheroids are moderately radiosensitive with
survival curves indicative of little or no capacity for repair of
sublethal damage. Parallel studies on radiosensitivity of
monolayer cells would be of interest but have so far been
prevented by difficulties in obtaining discrete colony for-
mation by NBI-G cells. However, it is likely that tumour
spheroids provide the more realistic in vitro model of human
cancer. These in vitro observations provide experimental
support for the clinical strategy of treating neuroblastoma
using hyperfractionated radiotherapy (Deacon et al., 1985;
Wheldon et al., 1985; 1986). Other radiobiological studies to
which NBI-G cells lend themselves include experimental
treatment by radioisotopes immunologically targeted by
monoclonal antibodies or biochemically targeted by means
of the catecholamine precursor MIBG (Treuner et al., 1984).
More generally, the retention of specific tumour properties
by cell lines in vitro provides encouragement that lines such
as NBI-G should be useful both for fundamental studies on
human cancer and for experimental investigation of
alternative approaches to therapy.
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